A Study of a Weight Loss Intervention in People With Endometrial Cancer
EARLY_PHASE1
36
about 2 years
18+
Female only
7 sites in NJ, NY
What this study is about
This trial is testing whether tirzepatide can help with weight management and blood sugar control for people with endometrial cancer who are undergoing chemotherapy. The researchers will also look at how safe it is to take the drug while receiving chemotherapy, as well as changes in weight, body fat, and blood pressure.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Tirzepatide
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
tirzepatide
injection (Injection)
Secondary: frequency of gastrointestinal adverse events
Oncology